Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study

Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study

BackgroundNon-alcoholic fatty liver disease (NAFLD) is common and is associated with cardiovascular (CV) disease and mortality. The Framingham steatosis index (FSI) was recently proposed as a diagnostic marker of NAFLD and was calculated from age, body mass index, triglyceride, aspartate aminotransf...

Full description

Bibliographic Details
Main Authors:	Yun Kyung Cho, Myungjin Kim, Ye-Jee Kim, Chang Hee Jung, Woo Je Lee, Joong-Yeol Park
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-07-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	cardiovascular disease risk cardiovascular mortality Framingham steatosis index non-alcoholic fatty liver disease diabetes and endocrine research
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2023.1163052/full

Similar Items

Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study
by: Si Hyoung Kim, et al.
Published: (2022-05-01)

Triglyceride-Glucose Index Predicts Cardiovascular Outcome in Metabolically Unhealthy Obese Population: A Nationwide Population-Based Cohort Study
by: Yun Kyung Cho, et al.
Published: (2022-06-01)

The Framingham Study on Cardiovascular Disease Risk and Stress-Defenses: A Historical Review
by: Mostafa Abohelwa, et al.
Published: (2023-02-01)

The risk of cardiovascular events based on the Framingham criteria in Adults Living in Mashhad (Iran)
by: Zeinab Shateri Amiri, et al.
Published: (2018-08-01)

Impact of modifiable risk factors on prediction of 10-year cardiovascular disease utilizing framingham risk score in Southwest Iran
by: Nader Saki, et al.
Published: (2023-07-01)

Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low‐Density Lipoprotein Cholesterol—The Framingham Heart Study
by: Mehdi Afshar, et al.
Published: (2020-09-01)

Riesgo cardiovascular según tablas de la OMS, el estudio Framingham y la razón apolipoproteína B/apolipoproteína A1 Cardiovascular risk according the OMS tables, the Framingham study and the B apolipoprotein/A1 apolipoprotein reason
by: Ivette Castillo Arocha, et al.
Published: (2010-12-01)

Metabolic Syndrome and Framingham Risk Score: Observation from Screening of Low-Income Semi-Urban African Women
by: Ayokunle S. Dada, et al.
Published: (2016-06-01)

KORELASI ANTARA PROTEINURIA DAN FRAMINGHAM RISK SCORE DALAM PENILAIAN RISIKO CARDIOVASCULAR DISEASE
by: Kevin Prasetya Raharjo, et al.
Published: (2017-05-01)

Cardiovascular risk prediction: a comparative study of Framingham and quantum neural network based approach
by: Narain R, et al.
Published: (2016-07-01)

Recalibration of Framingham risk for a local population of Sri Lanka
by: Sameera Upashantha Ranasinghe, et al.
Published: (2024-01-01)

A study to assess the future 10-year cardiovascular and 8-year diabetic risk by using Framingham heart scale in prediabetic subjects
by: Neeta Kumari, et al.
Published: (2022-09-01)

Prediction of Cardiovascular Disease by the Framingham‐REGICOR Equation in the High‐Risk PREDIMED Cohort: Impact of the Mediterranean Diet Across Different Risk Strata
by: Antonio J. Amor, et al.
Published: (2017-03-01)

Applying the Framingham risk score for prediction of metabolic syndrome: The Kerman Coronary Artery Disease Risk Study, Iran
by: Gholamreza Yousefzadeh, et al.
Published: (2015-05-01)

Agreement between Framingham, IraPEN and non-laboratory WHO-EMR risk score calculators for cardiovascular risk prediction in a large Iranian population
by: Mohsen Mirzaei, et al.
Published: (2020-02-01)

Assessment of the agreement between the Framingham and DAD risk equations for estimating cardiovascular risk in adult Africans living with HIV infection: a cross-sectional study
by: Steve Raoul Noumegni, et al.
Published: (2017-07-01)

Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials
by: Yu Mi Kang, et al.
Published: (2019-08-01)

Identification of Predictable Biomarkers in Conjunction to Framingham Risk Score to Predict the Risk for Cardiovascular disease (CVD) in Non Cardiac Subjects
by: Rama Krishna Reddy Y.V., et al.
Published: (2015-02-01)

2013 ACC/AHA Cholesterol Guideline Versus 2004 NCEP ATP III Guideline in the Prediction of Coronary Artery Calcification Progression in a Korean Population
by: Yun Kyung Cho, et al.
Published: (2016-08-01)

Estimation of Cardiovascular Risk by Framingham Score in a Cross-sectional Sample of Schizophrenia Inpatients
by: Cosmin-Ioan MOGA, et al.
Published: (2023-01-01)

Recalibration of the Framingham risk score for predicting 10-year risk of cardiovascular events: A non-concurrent rural cohort study from Tamil Nadu
by: Midhun Sasikumar, et al.
Published: (2023-01-01)

Family History of Modifiable Risk Factors and Association With Future Cardiovascular Disease
by: Christy N. Taylor, et al.
Published: (2023-03-01)

Implications of metabolic health status and obesity on the risk of kidney cancer: A nationwide population-based cohort study
by: Yun Kyung Cho, et al.
Published: (2022-10-01)

Identification of the Framingham Risk Score by an Entropy-Based Rule Model for Cardiovascular Disease
by: You-Shyang Chen, et al.
Published: (2020-12-01)

Impact of diabetes duration and degree of carotid artery stenosis on major adverse cardiovascular events: a single-center, retrospective, observational cohort study
by: Minsu Noh, et al.
Published: (2017-06-01)

RISCO DE INFARTO AGUDO DO MIOCARDIO EM PRATICANTES DE MUSCULAÇÃO DE UMA ACADEMIA DA CIDADE DE ITATIAIA-RJ
by: Thaís de Souza Rosa, et al.
Published: (2014-04-01)

Comparison of original and modified Q risk 2 risk score with Framingham risk score - An Indian perspective
by: Puneet Aggarwal, et al.
Published: (2021-05-01)

Response: Triglyceride-Glucose Index Predicts Cardiovascular Outcome in Metabolically Unhealthy Obese Population: A Nationwide Population-Based Cohort Study (J Obes Metab Syndr 2022;31:178-86)
by: Yun Kyung Cho, et al.
Published: (2023-06-01)

Durability of glucose-lowering effect of dulaglutide in patients with type 2 diabetes mellitus: A real-world data study
by: Hwi Seung Kim, et al.
Published: (2022-10-01)

The ten-year risk of developing cardiovascular disease among public health workers in North-Central Nigeria using Framingham and atherogenic index of plasma risk scores
by: Olubunmi Abiola Olubiyi, et al.
Published: (2022-04-01)

Where to Sit? Type of Sitting Matters for the Framingham Cardiovascular Risk Score
by: Katja Borodulin, et al.
Published: (2016-08-01)

Age‐Related Associations of Low‐Density Lipoprotein Cholesterol and Atherosclerotic Cardiovascular Disease: A Nationwide Population‐Based Cohort Study
by: Han Na Jung, et al.
Published: (2022-05-01)

Is endocan a novel potential biomarker of liver steatosis and fibrosis?
by: Klisić Aleksandra, et al.
Published: (2020-01-01)

Triglyceride Glucose-Waist Circumference Is Superior to the Homeostasis Model Assessment of Insulin Resistance in Identifying Nonalcoholic Fatty Liver Disease in Healthy Subjects
by: Hwi Seung Kim, et al.
Published: (2021-12-01)

A comparison of laboratory-based and office-based Framingham risk scores to predict 10-year risk of cardiovascular diseases: a population-based study
by: Azizallah Dehghan, et al.
Published: (2023-10-01)

APOL1 Gene Variants and Risk for Cardiovascular Disease
by: Carlos Eduardo Duran, et al.
Published: (2023-12-01)

Framingham risk score and risk of incident chronic kidney disease: A community-based prospective cohort study
by: Changhyun Lee, et al.
Published: (2019-03-01)

The paradoxical effect of aldosterone on cardiovascular outcome in maintenance hemodialysis patients
by: Sun Ryoung Choi, et al.
Published: (2022-01-01)

William Kannel and the Framingham Study
by: Eduardo Álvarez Acevedo
Published: (2022-04-01)

Comparison of cardiovascular disease risk in women with and without breast cancer: secondary data analysis with the 2014–2018 korean national health and nutrition examination survey
by: Seongmi Choi, et al.
Published: (2023-06-01)